In vivo and in vitro measurement of apoptosis in breast cancer cells usingTc-99m-EC-annexin V

Citation
Dj. Yang et al., In vivo and in vitro measurement of apoptosis in breast cancer cells usingTc-99m-EC-annexin V, CANC BIO R, 16(1), 2001, pp. 73-83
Citations number
61
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
ISSN journal
10849785 → ACNP
Volume
16
Issue
1
Year of publication
2001
Pages
73 - 83
Database
ISI
SICI code
1084-9785(200102)16:1<73:IVAIVM>2.0.ZU;2-M
Abstract
Objective: The purpose of this study was to develop an imaging technique to measure and monitor tumor cells undergoing programmed death caused by radi ation and chemotherapy using Tc-99m-EC-annexin V. Annexin V has been used t o measure programmed cell death both in vitro and in vivo. Assessment of ap optosis would be useful to evaluate the efficacy and mechanisms of therapy and disease progression or regression. Methods: Ethylenedicysteine (EC) was conjugated to annexin V using sulfo-N-hydroxysuccinimide and 1-ethyl-3-(3- dimethylaminopropyl) carbodiimide-HCl as coupling agents. The yield of EC-a nnexin V was 100%. In vitro cellular uptake, pre- and post-radiation (10-30 Gy) and paclitaxel treatment, was quantified using Tc-99m-EC-annexin V. Ti ssue distribution and planar imaging of Tc-99m-EC-annexin V were determined in breast tumor-bearing mts at 0.5, 2, and 4 hrs. To demonstrate in vivo c ell apoptosis that occurred during chemotherapy, a group of mts was treated with paclitaxel and planar imaging studies were conducted at 0.5-4 hrs. Co mputer outlined region of interest (ROI) was used to quantify tumor uptake on day 3 and clay 5 post-treatment. Results: In vitro cellular uptake showe d that there was significantly increased uptake of Tc-99m-EC-annexin V afte r irradiation (10-30 Gy) and paclitaxel treatment In vivo biodistribution o f Tc-99m-EC-annexin in breast tumor-bearing rats showed increased tumor-to- blood, tumor-to-lung and tumor-to-muscle count density ratios as a function of time. Conversely, tumor-to-blood count density ratios showed a time-dep endent decrease with Tc-99m-EC in the same time period Planar images confir med that the tumors could be visualized clearly with 99mTc-EC-annexin. Ther e was a significant difference of ROI ratios between pre- and post-paclitax el treatment groups at 2 and 4 hrs post injection. Conclusion: The results indicate that apoptosis can be quantified using Tc-99m-EC-annexin and that it is feasible to use Tc-99m-EC-annexin to image tumor apoptosis.